SELLAS Life Sciences (SLS) Other Non-Current Liabilities (2011 - 2022)
SELLAS Life Sciences (SLS) recorded Other Non-Current Liabilities of $170,000 in Q3 2022, down 96.6% from $5.04 million a year earlier and down 6.1% from the prior quarter.
Powered by 
Analysis
SELLAS Life Sciences (SLS) Other Non-Current Liabilities (2011 - 2022) Analysis & Trends
At the end of FY2021, SELLAS Life Sciences reported Other Non-Current Liabilities of $296,000, down 93.6% from FY2020.
- Annual Other Non-Current Liabilities has a five-year compound annual growth rate of -23.0% (FY2016 to FY2021).
- Across earlier years, Other Non-Current Liabilities came in at $4.63 million in FY2020 (-5.7%), $4.91 million in FY2019 (+13.5%), $4.33 million in FY2018 (+234.3%) and $1.29 million in FY2017 (+18.2%).
- The Q3 2022 figure is the lowest quarterly Other Non-Current Liabilities in data going back to Q2 2011.
- On a year-over-year basis, Other Non-Current Liabilities has declined for eight consecutive quarters, with an average decline of 50.0% over the last eight quarters.
- Peak year-over-year performance for Other Non-Current Liabilities in the last five years was growth of 320.3% in Q2 2018, against a decline of 96.6% in Q3 2022 at the low end.
- Per Business Quant, the preceding three quarters came in at $181,000 (Q2 2022), $296,000 (Q1 2022) and $296,000 (Q4 2021).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | SELLAS Life Sciences | 2.49 Bn | 2.49 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2022 | 170,000.00 |
| Jun 30, 2022 | 181,000.00 |
| Mar 31, 2022 | 296,000.00 |
| Dec 31, 2021 | 296,000.00 |
| Sep 30, 2021 | 5.04 Mn |
| Jun 30, 2021 | 4.90 Mn |
| Mar 31, 2021 | 4.76 Mn |
| Dec 31, 2020 | 4.63 Mn |
| Sep 30, 2020 | 5.18 Mn |
| Jun 30, 2020 | 5.19 Mn |
| Mar 31, 2020 | 5.05 Mn |
| Dec 31, 2019 | 4.91 Mn |
| Sep 30, 2019 | 4.84 Mn |
| Jun 30, 2019 | 4.81 Mn |
| Mar 31, 2019 | 4.71 Mn |
| Dec 31, 2018 | 4.33 Mn |
| Sep 30, 2018 | 5.32 Mn |
| Jun 30, 2018 | 5.16 Mn |
| Mar 31, 2018 | 4.71 Mn |
| Dec 31, 2017 | 1.29 Mn |
API Access
SELLAS Life Sciences Other Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=SLS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-liabilities", "ticker": "SLS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=SLS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();